Physician profile
Eric Roberts
NPI 1235536939
$5,467.38
in general payments reported to CMS, 2019-2025
20 companies · $1,560 in 2025
The $1,560 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $387 · 2023: $1,412 · 2024: $2,108 · 2025: $1,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,911 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,911.01 |
| Education | $168.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $833.11 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $550.60 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $533.90 | 2022-2025 | |
| Genzyme Corporation | $426.85 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $399.10 | 2023-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $392.55 | 2023-2025 | Tremfya, Simponi Aria, Remicade |
| Amgen INC. | $361.57 | 2022-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $355.73 | 2022-2025 | Ilumya |
| Incyte Corporation | $314.02 | 2023-2025 | Opzelura |
| Galderma Laboratories, L.P. | $221.16 | 2023-2025 | Nemluvio, Aklief |
| Lilly USA, LLC | $212.68 | 2023-2025 | Ebglyss, Taltz, Olumiant |
| Leo Pharma INC. | $194.39 | 2022-2025 | Adbry, Anzupgo, Spevigo |
| Dermavant Sciences, INC. | $183.32 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $170.57 | 2023-2025 | Zoryve |
| Pfizer INC. | $102.53 | 2022-2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $78.58 | 2024-2025 | Bimzelx |
| Almirall LLC | $63.86 | 2024-2025 | Klisyri, Seysara |
| Verrica Pharmaceuticals INC. | $27.87 | 2024 | Ycanth |
| Mayne Pharma Commercial LLC | $23.65 | 2022 | |
| Botanix Sb INC | $21.34 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.